Telomere Length and Human Telomerase Reverse Transcriptase Expression As Markers for Progression and Prognosis of Colorectal Carcinoma
Maintenance of telomeres through reactivation of telomerase is a prerequisite for tumors to preserve their ability to proliferate. The purpose of this study was to evaluate telomere length and human telomerase reverse transcriptase (hTERT) expression as markers for progression and prognosis of color...
Saved in:
Published in | Journal of clinical oncology Vol. 22; no. 10; pp. 1807 - 1814 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Baltimore, MD
American Society of Clinical Oncology
15.05.2004
Lippincott Williams & Wilkins |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Maintenance of telomeres through reactivation of telomerase is a prerequisite for tumors to preserve their ability to proliferate. The purpose of this study was to evaluate telomere length and human telomerase reverse transcriptase (hTERT) expression as markers for progression and prognosis of colorectal carcinoma.
Telomere length and hTERT expression were analyzed in matched cancer and adjacent noncancer mucosa samples from 57 patients with R0-resected colorectal carcinoma. The median follow-up time was 76 months.
Telomere length and hTERT expression correlated significantly in cancer tissues and adjacent mucosa samples (r = 0.52, P <.001; and r = 0.54, P <.001, respectively). Overall, cancer tissue had shorter telomeres than adjacent mucosa (P <.001). Only in noncancer tissue did telomere length decrease with age (r = 0.36; P <.01). Telomere length in cancer tissue was significantly correlated with tumor stage (P <.01), with longer telomeres in advanced tumors. Patients with ratios of telomere length in cancer to noncancer tissue greater than 0.90 had a significantly poorer overall survival compared with patients with smaller telomere length ratios (P <.002). In multivariate analysis, the telomere length ratio proved to be of independent prognostic value (P <.03).
Telomeres in colorectal carcinoma tissue were significantly shorter compared with adjacent normal mucosa as an indication for extensive cell proliferation. The correlation with tumor stage and patient survival suggest that hTERT-mediated telomere stabilization may be critical for progression and prognosis of colorectal carcinoma. |
---|---|
AbstractList | Purpose
Maintenance of telomeres through reactivation of telomerase is a prerequisite for tumors to preserve their ability to proliferate. The purpose of this study was to evaluate telomere length and human telomerase reverse transcriptase (hTERT) expression as markers for progression and prognosis of colorectal carcinoma.
Patients and Methods
Telomere length and hTERT expression were analyzed in matched cancer and adjacent noncancer mucosa samples from 57 patients with R0-resected colorectal carcinoma. The median follow-up time was 76 months.
Results
Telomere length and hTERT expression correlated significantly in cancer tissues and adjacent mucosa samples (r = 0.52, P < .001; and r = 0.54, P < .001, respectively). Overall, cancer tissue had shorter telomeres than adjacent mucosa (P < .001). Only in noncancer tissue did telomere length decrease with age (r = 0.36; P < .01). Telomere length in cancer tissue was significantly correlated with tumor stage (P < .01), with longer telomeres in advanced tumors. Patients with ratios of telomere length in cancer to noncancer tissue greater than 0.90 had a significantly poorer overall survival compared with patients with smaller telomere length ratios (P < .002). In multivariate analysis, the telomere length ratio proved to be of independent prognostic value (P < .03).
Conclusion
Telomeres in colorectal carcinoma tissue were significantly shorter compared with adjacent normal mucosa as an indication for extensive cell proliferation. The correlation with tumor stage and patient survival suggest that hTERT-mediated telomere stabilization may be critical for progression and prognosis of colorectal carcinoma. Maintenance of telomeres through reactivation of telomerase is a prerequisite for tumors to preserve their ability to proliferate. The purpose of this study was to evaluate telomere length and human telomerase reverse transcriptase (hTERT) expression as markers for progression and prognosis of colorectal carcinoma. Telomere length and hTERT expression were analyzed in matched cancer and adjacent noncancer mucosa samples from 57 patients with R0-resected colorectal carcinoma. The median follow-up time was 76 months. Telomere length and hTERT expression correlated significantly in cancer tissues and adjacent mucosa samples (r = 0.52, P <.001; and r = 0.54, P <.001, respectively). Overall, cancer tissue had shorter telomeres than adjacent mucosa (P <.001). Only in noncancer tissue did telomere length decrease with age (r = 0.36; P <.01). Telomere length in cancer tissue was significantly correlated with tumor stage (P <.01), with longer telomeres in advanced tumors. Patients with ratios of telomere length in cancer to noncancer tissue greater than 0.90 had a significantly poorer overall survival compared with patients with smaller telomere length ratios (P <.002). In multivariate analysis, the telomere length ratio proved to be of independent prognostic value (P <.03). Telomeres in colorectal carcinoma tissue were significantly shorter compared with adjacent normal mucosa as an indication for extensive cell proliferation. The correlation with tumor stage and patient survival suggest that hTERT-mediated telomere stabilization may be critical for progression and prognosis of colorectal carcinoma. PURPOSEMaintenance of telomeres through reactivation of telomerase is a prerequisite for tumors to preserve their ability to proliferate. The purpose of this study was to evaluate telomere length and human telomerase reverse transcriptase (hTERT) expression as markers for progression and prognosis of colorectal carcinoma.PATIENTS AND METHODSTelomere length and hTERT expression were analyzed in matched cancer and adjacent noncancer mucosa samples from 57 patients with R0-resected colorectal carcinoma. The median follow-up time was 76 months.RESULTSTelomere length and hTERT expression correlated significantly in cancer tissues and adjacent mucosa samples (r = 0.52, P <.001; and r = 0.54, P <.001, respectively). Overall, cancer tissue had shorter telomeres than adjacent mucosa (P <.001). Only in noncancer tissue did telomere length decrease with age (r = 0.36; P <.01). Telomere length in cancer tissue was significantly correlated with tumor stage (P <.01), with longer telomeres in advanced tumors. Patients with ratios of telomere length in cancer to noncancer tissue greater than 0.90 had a significantly poorer overall survival compared with patients with smaller telomere length ratios (P <.002). In multivariate analysis, the telomere length ratio proved to be of independent prognostic value (P <.03).CONCLUSIONTelomeres in colorectal carcinoma tissue were significantly shorter compared with adjacent normal mucosa as an indication for extensive cell proliferation. The correlation with tumor stage and patient survival suggest that hTERT-mediated telomere stabilization may be critical for progression and prognosis of colorectal carcinoma. |
Author | Dominik Stricker Martin Werner Hjalmar Nekarda Ralf Gertler Robert Rosenberg Joerg-Ruediger Siewert Jan Friederichs Bernhard Holzmann Axel Hoos Kurt Ulm |
Author_xml | – sequence: 1 givenname: Ralf surname: GERTLER fullname: GERTLER, Ralf organization: Chirurgische Klinik und Poliklinik, Institut für Pathologie und Pathologische Anatomie, and Institut für Medizinische Statistik und Epidemiologie, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany – sequence: 2 givenname: Robert surname: ROSENBERG fullname: ROSENBERG, Robert organization: Chirurgische Klinik und Poliklinik, Institut für Pathologie und Pathologische Anatomie, and Institut für Medizinische Statistik und Epidemiologie, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany – sequence: 3 givenname: Dominik surname: STRICKER fullname: STRICKER, Dominik organization: Chirurgische Klinik und Poliklinik, Institut für Pathologie und Pathologische Anatomie, and Institut für Medizinische Statistik und Epidemiologie, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany – sequence: 4 givenname: Jan surname: FRIEDERICHS fullname: FRIEDERICHS, Jan organization: Chirurgische Klinik und Poliklinik, Institut für Pathologie und Pathologische Anatomie, and Institut für Medizinische Statistik und Epidemiologie, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany – sequence: 5 givenname: Axel surname: HOOS fullname: HOOS, Axel organization: Chirurgische Klinik und Poliklinik, Institut für Pathologie und Pathologische Anatomie, and Institut für Medizinische Statistik und Epidemiologie, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany – sequence: 6 givenname: Martin surname: WERNER fullname: WERNER, Martin organization: Chirurgische Klinik und Poliklinik, Institut für Pathologie und Pathologische Anatomie, and Institut für Medizinische Statistik und Epidemiologie, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany – sequence: 7 givenname: Kurt surname: ULM fullname: ULM, Kurt organization: Chirurgische Klinik und Poliklinik, Institut für Pathologie und Pathologische Anatomie, and Institut für Medizinische Statistik und Epidemiologie, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany – sequence: 8 givenname: Bernhard surname: HOLZMANN fullname: HOLZMANN, Bernhard organization: Chirurgische Klinik und Poliklinik, Institut für Pathologie und Pathologische Anatomie, and Institut für Medizinische Statistik und Epidemiologie, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany – sequence: 9 givenname: Hjalmar surname: NEKARDA fullname: NEKARDA, Hjalmar organization: Chirurgische Klinik und Poliklinik, Institut für Pathologie und Pathologische Anatomie, and Institut für Medizinische Statistik und Epidemiologie, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany – sequence: 10 givenname: Joerg-Ruediger surname: SIEWERT fullname: SIEWERT, Joerg-Ruediger organization: Chirurgische Klinik und Poliklinik, Institut für Pathologie und Pathologische Anatomie, and Institut für Medizinische Statistik und Epidemiologie, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15764676$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/15143073$$D View this record in MEDLINE/PubMed |
BookMark | eNpNkEtv1DAYRS1URKeFNTvkDbDK1I_ETpZVVChoUBEaJHaW43yecUnsqZ3h8Qf43ThMEKyu7Ht8ZZ0LdOaDB4SeU7KmjJCr9-3dOme5Js2aCvIIrWjFZCFlVZ2hFZGcFbTmX87RRUr3hNCy5tUTdE4rWvLcrtCvLQxhhAh4A3437bH2Pb49jtrjpdEJ8Cf4BjHnNmqfTHSHab69-XGIkJILHl8n_EHHrxnCNkT8MYbd32oenM8-JJdwsLgNQ4hgJj3gVkfjfBj1U_TY6iHBsyUv0ec3N9v2ttjcvX3XXm8KwxsxFWXFNDBOytKympGuIYRbIfvegu0Yp6IiwlogVvSNpp1lTSOhZ0SA7EpmJL9Er067hxgejpAmNbpkYBi0h3BMStKGl7SpM3h1Ak0MKUWw6hDdqONPRYma1ausXs3qFWlUVp9fvFimj90I_T9-cZ2Blwugk9GDzS6NS_9xUpRCisy9PnF7t9t_dxFUGvUw5Fmm7k1g7M8X6jz5G7M6nQY |
CitedBy_id | crossref_primary_10_1007_s11684_016_0450_2 crossref_primary_10_1007_s12094_016_1559_0 crossref_primary_10_1002_cncr_23419 crossref_primary_10_1089_gtmb_2015_0150 crossref_primary_10_1016_j_prp_2010_05_009 crossref_primary_10_1016_j_cancergen_2019_07_007 crossref_primary_10_3892_ol_2017_6284 crossref_primary_10_1038_bjc_2014_561 crossref_primary_10_1002_hon_937 crossref_primary_10_1002_jso_23894 crossref_primary_10_1515_CCLM_2010_049 crossref_primary_10_1111_j_1745_7254_2007_00488_x crossref_primary_10_3390_cancers14092250 crossref_primary_10_1016_j_bbamcr_2019_07_001 crossref_primary_10_1038_sj_leu_2404141 crossref_primary_10_1200_JCO_2005_04_2127 crossref_primary_10_3390_cancers15041159 crossref_primary_10_1093_jnci_djt191 crossref_primary_10_1158_1078_0432_CCR_18_0630 crossref_primary_10_1007_s12032_010_9506_3 crossref_primary_10_4155_bio_12_203 crossref_primary_10_1016_j_tranon_2019_05_010 crossref_primary_10_1111_j_1349_7006_2010_01782_x crossref_primary_10_1586_era_12_3 crossref_primary_10_7314_APJCP_2012_13_2_443 crossref_primary_10_1002_ijc_23376 crossref_primary_10_1186_s12885_016_2997_3 crossref_primary_10_1371_journal_pone_0107268 crossref_primary_10_1038_onc_2013_446 crossref_primary_10_1016_j_jgo_2013_09_001 crossref_primary_10_1177_1099800413519495 crossref_primary_10_18632_oncotarget_9015 crossref_primary_10_1097_01_ju_0000143195_49685_ce crossref_primary_10_4251_wjgo_v1_i1_3 crossref_primary_10_1371_journal_pone_0149626 crossref_primary_10_1007_s40291_018_0336_x crossref_primary_10_1007_s12094_011_0673_2 crossref_primary_10_1111_j_1463_1318_2010_02433_x crossref_primary_10_1093_carcin_bgr053 crossref_primary_10_1126_sciadv_add8023 crossref_primary_10_18632_oncotarget_5968 crossref_primary_10_1158_1078_0432_CCR_10_3271 crossref_primary_10_1155_2012_598984 crossref_primary_10_1016_j_ejca_2004_11_024 crossref_primary_10_18632_oncotarget_20055 crossref_primary_10_1182_blood_2007_05_092759 crossref_primary_10_1016_j_prp_2016_11_010 crossref_primary_10_1152_physrev_00020_2018 crossref_primary_10_1586_17474124_2013_848790 crossref_primary_10_1172_JCI86042 crossref_primary_10_1042_bse0480147 crossref_primary_10_1158_0008_5472_CAN_08_3513 crossref_primary_10_12688_f1000research_19091_1 crossref_primary_10_1002_cncr_21625 crossref_primary_10_3389_fonc_2015_00296 crossref_primary_10_1111_j_1442_2042_2006_01300_x crossref_primary_10_1016_j_jgo_2021_12_008 crossref_primary_10_1002_iub_1758 crossref_primary_10_1017_S146239941000147X crossref_primary_10_18632_oncotarget_9796 crossref_primary_10_3389_fonc_2019_01172 crossref_primary_10_1371_journal_pone_0064296 crossref_primary_10_1002_ijc_31978 crossref_primary_10_1172_JCI43452 crossref_primary_10_1016_j_bbadis_2009_02_006 crossref_primary_10_1016_j_febslet_2005_04_021 crossref_primary_10_18632_oncotarget_1829 crossref_primary_10_1007_s11033_008_9295_3 crossref_primary_10_1038_s41416_019_0525_3 crossref_primary_10_1590_1414_431x20176019 crossref_primary_10_1007_s12032_011_9866_3 crossref_primary_10_1016_j_yexmp_2017_05_010 crossref_primary_10_3390_ijms18091871 crossref_primary_10_1093_bib_bby020 crossref_primary_10_1038_labinvest_3700710 crossref_primary_10_1038_s41419_022_04885_8 crossref_primary_10_18632_genesandcancer_140 crossref_primary_10_1007_s00401_015_1432_1 crossref_primary_10_1097_PPO_0000000000000665 crossref_primary_10_1016_j_ctrv_2016_08_007 crossref_primary_10_1080_00313020600580468 crossref_primary_10_1016_S1470_2045_13_70110_4 crossref_primary_10_1007_s13277_015_3545_5 crossref_primary_10_3945_jn_109_104984 crossref_primary_10_1002_mc_22567 crossref_primary_10_1007_s11888_009_0028_3 crossref_primary_10_1038_s41597_024_03562_z crossref_primary_10_1038_modpathol_3800504 crossref_primary_10_1038_onc_2012_441 crossref_primary_10_1002_ijc_22120 crossref_primary_10_1371_journal_pone_0133174 crossref_primary_10_1158_1078_0432_CCR_08_0478 crossref_primary_10_1111_bjh_14244 crossref_primary_10_1093_annonc_mdn394 crossref_primary_10_1016_S1470_2045_08_70234_1 crossref_primary_10_1016_j_humpath_2006_08_019 crossref_primary_10_1371_journal_pone_0109921 crossref_primary_10_3389_fmolb_2022_1100285 crossref_primary_10_1016_j_ajpath_2011_05_056 crossref_primary_10_1177_117727190700200030 crossref_primary_10_1002_cncr_22132 crossref_primary_10_3390_medicina56090463 crossref_primary_10_1111_j_1582_4934_2011_01284_x crossref_primary_10_1016_j_saa_2018_02_024 crossref_primary_10_1016_j_molmed_2012_11_006 crossref_primary_10_1053_j_gastro_2009_12_065 crossref_primary_10_4236_jct_2014_513118 crossref_primary_10_1007_s12032_010_9444_0 crossref_primary_10_3892_br_2015_444 crossref_primary_10_1593_neo_07106 crossref_primary_10_1111_bjh_13023 crossref_primary_10_1080_14737159_2017_1337511 crossref_primary_10_1089_gtmb_2013_0436 crossref_primary_10_1016_j_tjog_2019_11_007 crossref_primary_10_1016_j_febslet_2011_07_005 crossref_primary_10_1038_bjc_2012_602 crossref_primary_10_1593_neo_05715 crossref_primary_10_1158_1055_9965_EPI_05_0542 crossref_primary_10_1016_j_ejca_2009_07_008 crossref_primary_10_1016_j_ejphar_2017_05_039 crossref_primary_10_18632_oncotarget_339 crossref_primary_10_1016_S0140_6736_05_17706_X crossref_primary_10_3748_wjg_v22_i25_5678 crossref_primary_10_1038_sj_bjc_6605644 crossref_primary_10_1158_1055_9965_EPI_09_0360 crossref_primary_10_1016_j_bbadis_2009_01_017 crossref_primary_10_1016_j_jhep_2013_05_011 crossref_primary_10_1016_j_oraloncology_2015_02_100 crossref_primary_10_3390_ijms23020852 crossref_primary_10_1515_CCLM_2007_133 |
Cites_doi | 10.1200/JCO.2000.18.13.2582 10.1126/science.7605428 10.1002/cncr.10939 10.1002/(SICI)1098-2744(199912)26:4<312::AID-MC10>3.0.CO;2-A 10.1093/clinchem/46.3.313 10.1073/pnas.96.7.3339 10.1038/346866a0 10.1038/sj.neo.7900112 10.1038/22780 10.1080/01621459.1958.10501452 10.1016/0092-8674(89)90035-4 10.1007/s004320050294 10.1038/sj.neo.7900113 10.1055/s-2007-1024277 10.1016/S0304-3835(00)00521-8 10.1111/j.2517-6161.1972.tb00899.x 10.1038/ng1297-498 10.1038/ng0198-65 10.1038/13495 10.1002/(SICI)1097-0142(19991015)86:8<1431::AID-CNCR7>3.0.CO;2-R 10.3892/ijo.16.6.1173 10.1002/j.1460-2075.1992.tb05245.x 10.1056/NEJMra021902 10.1038/sj.onc.1202458 10.1126/science.279.5349.349 10.1111/j.1572-0241.2001.03890.x 10.1038/554 10.1002/1097-0215(200002)9999:9999<::AID-IJC1103>3.0.CO;2-V 10.1038/350569a0 |
ContentType | Journal Article |
Copyright | 2004 INIST-CNRS |
Copyright_xml | – notice: 2004 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1200/JCO.2004.09.160 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1527-7755 |
EndPage | 1814 |
ExternalDocumentID | 10_1200_JCO_2004_09_160 15143073 15764676 jco22_10_1807 |
Genre | Evaluation Studies Journal Article |
GeographicLocations | Germany |
GeographicLocations_xml | – name: Germany |
GroupedDBID | - 0R 2WC 34G 39C 3O- 4.4 53G 55 5GY 5RE 8F7 8WZ A6W AAPEM AARDX AAWTL AAYEP ABFLS ABOCM ACDCL ACGFS ADBBV ADBIT ADKWQ AENEX AFFNX ALMA_UNASSIGNED_HOLDINGS ASPBG AVWKF AWKKM AZFZN BAWUL CS3 DIK EBS EJD F5P FD8 FH7 GJ GX1 H13 HZ IH2 K-O KQ8 L7B LSO N9A NTWIH O9- OK1 OVD OWW P2P RHI RUC SJN SV3 TWZ UDS VH1 WH7 X7M YCJ ZA5 ZGI --- .55 .GJ 08G 08P 08R 0R~ 18M 29K 5VS AAKAS AAQQT AAUGY AAYOK ACGFO ADZCM AEGXH AI. AIAGR C45 D-I EX3 F9R FBNNL FEDTE HZ~ IPNFZ IQODW J5H MJL N4W QTD R1G RIG RLZ TEORI TR2 UHU VVN WOQ WOW YFH YQY ABJNI ACGUR CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c396t-452ae23044f2820b9003f67ddfefb2316506ffe0f6d9a1bf2997ed206e7b42c73 |
ISSN | 0732-183X |
IngestDate | Fri Oct 25 04:01:10 EDT 2024 Fri Aug 23 03:02:04 EDT 2024 Sat Sep 28 07:41:32 EDT 2024 Sun Oct 22 16:05:47 EDT 2023 Tue Jan 05 20:17:21 EST 2021 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Keywords | Human Rectal disease Prognosis RNA-directed DNA polymerase Enzyme Transferases Colorectal cancer Biological marker Reverse transcription Malignant tumor Telomere Colonic disease Nucleotidyltransferases Digestive diseases Intestinal disease Telomerase |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c396t-452ae23044f2820b9003f67ddfefb2316506ffe0f6d9a1bf2997ed206e7b42c73 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2004.09.160?role=tab |
PMID | 15143073 |
PQID | 71934198 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_71934198 crossref_primary_10_1200_JCO_2004_09_160 pubmed_primary_15143073 pascalfrancis_primary_15764676 highwire_smallpub2_jco22_10_1807 |
ProviderPackageCode | RHI |
PublicationCentury | 2000 |
PublicationDate | 2004-05-15 |
PublicationDateYYYYMMDD | 2004-05-15 |
PublicationDate_xml | – month: 05 year: 2004 text: 2004-05-15 day: 15 |
PublicationDecade | 2000 |
PublicationPlace | Baltimore, MD |
PublicationPlace_xml | – name: Baltimore, MD – name: United States |
PublicationTitle | Journal of clinical oncology |
PublicationTitleAlternate | J Clin Oncol |
PublicationYear | 2004 |
Publisher | American Society of Clinical Oncology Lippincott Williams & Wilkins |
Publisher_xml | – name: American Society of Clinical Oncology – name: Lippincott Williams & Wilkins |
References | R21 R20 R23 R22 R25 R24 R27 R26 R29 R28 R1 R2 R3 R4 R5 R6 R7 R8 R9 R30 R10 R32 R31 R12 R34 R11 R33 R14 R13 R35 R16 R15 R18 R17 R19 |
References_xml | – ident: R30 doi: 10.1200/JCO.2000.18.13.2582 – ident: R7 doi: 10.1126/science.7605428 – ident: R17 doi: 10.1002/cncr.10939 – ident: R24 doi: 10.1002/(SICI)1098-2744(199912)26:4<312::AID-MC10>3.0.CO;2-A – ident: R26 doi: 10.1093/clinchem/46.3.313 – ident: R23 – ident: R5 doi: 10.1073/pnas.96.7.3339 – ident: R2 doi: 10.1038/346866a0 – ident: R34 doi: 10.1038/sj.neo.7900112 – ident: R9 doi: 10.1038/22780 – ident: R21 doi: 10.1080/01621459.1958.10501452 – ident: R6 doi: 10.1016/0092-8674(89)90035-4 – ident: R28 doi: 10.1007/s004320050294 – ident: R35 doi: 10.1038/sj.neo.7900113 – ident: R16 – ident: R4 doi: 10.1055/s-2007-1024277 – ident: R18 – ident: R19 doi: 10.1016/S0304-3835(00)00521-8 – ident: R31 – ident: R22 doi: 10.1111/j.2517-6161.1972.tb00899.x – ident: R11 doi: 10.1038/ng1297-498 – ident: R14 – ident: R10 doi: 10.1038/ng0198-65 – ident: R13 doi: 10.1038/13495 – ident: R20 doi: 10.1002/(SICI)1097-0142(19991015)86:8<1431::AID-CNCR7>3.0.CO;2-R – ident: R32 doi: 10.3892/ijo.16.6.1173 – ident: R3 doi: 10.1002/j.1460-2075.1992.tb05245.x – ident: R8 doi: 10.1056/NEJMra021902 – ident: R25 doi: 10.1038/sj.onc.1202458 – ident: R12 doi: 10.1126/science.279.5349.349 – ident: R29 doi: 10.1111/j.1572-0241.2001.03890.x – ident: R15 – ident: R27 doi: 10.1038/554 – ident: R33 doi: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1103>3.0.CO;2-V – ident: R1 doi: 10.1038/350569a0 |
SSID | ssj0014835 |
Score | 2.2561269 |
Snippet | Maintenance of telomeres through reactivation of telomerase is a prerequisite for tumors to preserve their ability to proliferate. The purpose of this study... Purpose Maintenance of telomeres through reactivation of telomerase is a prerequisite for tumors to preserve their ability to proliferate. The purpose of this... PURPOSEMaintenance of telomeres through reactivation of telomerase is a prerequisite for tumors to preserve their ability to proliferate. The purpose of this... |
SourceID | proquest crossref pubmed pascalfrancis highwire |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1807 |
SubjectTerms | Adult Aged Aged, 80 and over Biological and medical sciences Biomarkers, Tumor - biosynthesis Biomarkers, Tumor - genetics Blotting, Southern Case-Control Studies Colorectal Neoplasms - genetics Colorectal Neoplasms - metabolism Colorectal Neoplasms - mortality Colorectal Neoplasms - pathology Colorectal Neoplasms - surgery DNA-Binding Proteins Female Gastroenterology. Liver. Pancreas. Abdomen Gene Expression Regulation, Neoplastic Germany Humans Male Medical sciences Middle Aged Neoplasm Staging Polymerase Chain Reaction Predictive Value of Tests Prognosis Proportional Hazards Models RNA, Messenger - analysis Stomach. Duodenum. Small intestine. Colon. Rectum. Anus Survival Analysis Telomerase - biosynthesis Telomerase - genetics Telomere - metabolism Tumors |
Title | Telomere Length and Human Telomerase Reverse Transcriptase Expression As Markers for Progression and Prognosis of Colorectal Carcinoma |
URI | http://jco.ascopubs.org/content/22/10/1807.abstract https://www.ncbi.nlm.nih.gov/pubmed/15143073 https://search.proquest.com/docview/71934198 |
Volume | 22 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBAvCMatXIYf0ITEAonrOskjtN06xtap66S-RU5iS6A2Qb1IjB_Ar-THcE7sXDqKuLxEVSI7rb6vx-fY53yHkJdCp1xqjztJ7CqHCwhQAjcNHU_yOAl9N0iLE93TMzG85B-m3Wmr9aORtbRexW-Sb1vrSv4HVbgHuGKV7D8gW00KN-Az4AtXQBiuf4exmuVztVCvsR2KrVEzTfdW5gksUVicAi6ewmYQmbEReFd9tRmwGXaamWOSzqKQZjAZW-WjQkUgx2Q8o1uCGtdoI1FVBLsQZbm167_6t1XNZZ4lG3v3R4Px5KNNwJAzXR35jC4GZ-8H46M64bva_pmMj3snZkg_RzWUqr7ocHw86GNW7PDCJP1mG_sYHI_gTSWn2cfYokdR7GN8mmGyUMMs-h3mgCGamhXMmm3mQ5xgBH9Lu85Yk79uw0p7gem0a1d8cHL41tWEmUbZvVGxj4B6uJ5pfrCp231tPa2yHD2I5WAdEjfITQZmEBMO-8cn1RkXD0z71_L3WOEpeNXba6_c9JlKHWtM45VLwFGbFiy_j5EKX2lyl9yxJKDvDGPvkZbKdsmtU5vGsUv2z41g-tUBndT1f8sDuk_Payn1q_vke8lwahhOgZC0YDitGU4tw-kGw2nNcCqX1DKcAsNpg-HFhBXDaa5pzXBaMfwBuTwcTHpDx3YOcZJOKFYO7zKp8LiDawYubozb9Vr4aaqVjiGigbBEaK1cLdJQerEGn8xXKXOF8mPOEr_zkOxkeaYeE8o9nXR0R3RlmPI05hLwUonQvvT8QIukTV6V2ERfjEBMhIE1w1Pi3gjbvPLIDSOAsU1oiV20nMvZDDBi0eckZ6wYAqxsk70NTOspLZfa5EUJcgQLAZ7uyUzl62XkQyjGvTBok0cG-8ZYCIrgaz_50-RPye36n_mM7KwWa_UcfO5VvFdQ9yf3Xd0j |
link.rule.ids | 315,783,787,27938,27939 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Telomere+length+and+human+telomerase+reverse+transcriptase+expression+as+markers+for+progression+and+prognosis+of+colorectal+carcinoma&rft.jtitle=Journal+of+clinical+oncology&rft.au=GERTLER%2C+Ralf&rft.au=ROSENBERG%2C+Robert&rft.au=STRICKER%2C+Dominik&rft.au=FRIEDERICHS%2C+Jan&rft.date=2004-05-15&rft.pub=Lippincott+Williams+%26+Wilkins&rft.issn=0732-183X&rft.eissn=1527-7755&rft.volume=22&rft.issue=10&rft.spage=1807&rft.epage=1814&rft_id=info:doi/10.1200%2FJCO.2004.09.160&rft.externalDBID=n%2Fa&rft.externalDocID=15764676 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0732-183X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0732-183X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0732-183X&client=summon |